CN106929495A - 提高比活的α‑淀粉酶BasAmy突变体及其编码基因和应用 - Google Patents

提高比活的α‑淀粉酶BasAmy突变体及其编码基因和应用 Download PDF

Info

Publication number
CN106929495A
CN106929495A CN201710030849.7A CN201710030849A CN106929495A CN 106929495 A CN106929495 A CN 106929495A CN 201710030849 A CN201710030849 A CN 201710030849A CN 106929495 A CN106929495 A CN 106929495A
Authority
CN
China
Prior art keywords
basamy
sport
mutant
ams
living
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710030849.7A
Other languages
English (en)
Other versions
CN106929495B (zh
Inventor
李阳源
王建荣
黄江
聂金梅
陈丽芝
何小梅
杨玲
黄佳乐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yiduoli Biological Science & Tech Co Ltd Guangdong
Original Assignee
Yiduoli Biological Science & Tech Co Ltd Guangdong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yiduoli Biological Science & Tech Co Ltd Guangdong filed Critical Yiduoli Biological Science & Tech Co Ltd Guangdong
Priority to CN201911068115.3A priority Critical patent/CN110628748B/zh
Priority to CN201710030849.7A priority patent/CN106929495B/zh
Priority to CN201911068186.3A priority patent/CN110699337B/zh
Priority to CN201911068182.5A priority patent/CN110713999B/zh
Publication of CN106929495A publication Critical patent/CN106929495A/zh
Priority to PCT/CN2017/107821 priority patent/WO2018129985A1/zh
Application granted granted Critical
Publication of CN106929495B publication Critical patent/CN106929495B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411Amylases
    • C12N9/2414Alpha-amylase (3.2.1.1.)
    • C12N9/2417Alpha-amylase (3.2.1.1.) from microbiological source
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01001Alpha-amylase (3.2.1.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

本发明涉及基因工程领域,具体涉及提高比活的α‑淀粉酶BasAmy突变体及其编码基因和应用。所述突变位点为:氨基酸序列如SEQ ID NO.6所示的α‑淀粉酶BasAmy的29位由L突变为A;267位由S突变为Q;270位由S突变为P;275位由A突变为Y;350位由D突变为G;112位由A突变为R;269位由L突变为F;274位由K突变为S;278位由Q突变为S;279位由S突变为Q;和/或412为由L突变为C。本发明获得的突变体的比活较原酶提高。

Description

提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用
技术领域
本发明涉及基因工程领域,具体涉及提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用。
背景技术
α-淀粉酶是一种十分重要的酶制剂,能够从淀粉分子内部随机切开α-1,4糖苷键生成糊精和还原糖。α-淀粉酶广泛应用于食品工业、酿造、发酵和纺织品工业。
α-淀粉酶分布十分广泛,遍及微生物至高等植物。相对于其他来源的α-淀粉酶,微生物来源的α-淀粉酶作用温度广,pH值范围广,生产成本低,因此微生物来源的α-淀粉酶被广泛的应用于各个工业领域。作为微生物α-淀粉酶中最重要的一类,芽孢杆菌α-淀粉酶是目前研究和应用最为广泛。
沙漠芽胞杆菌(Bacillus sonorensis)α-淀粉酶简称BasAmy,是一种中温α-淀粉酶,其作用pH广,适用于食品、造纸、饲料等工业领域。相对于其他芽孢杆菌α-淀粉酶,BasAmy比活低,生产成本高,限制了其在食品、造纸、饲料等工业领域的应用。因此,提高BasAmy的比活,降低其生产成本,是BasAmy工业化应用急需解决的问题。
发明内容
本发明对来源于索诺拉沙漠芽胞杆菌的α-淀粉酶BasAmy进行分子改造,从而提高BasAmy的比活,降低生产成本,为α-淀粉酶BasAmy的工业化应用奠定基础。
本发明的目的是提供提高比活的α-淀粉酶BasAmy突变体。
本发明的再一目的是提供提高比活的α-淀粉酶BasAmy突变体的编码基因。
索诺拉沙漠芽胞杆菌的α-淀粉酶BasAmy的核苷酸序列和氨基酸序列分别如SEQID NO.1和SEQ ID NO.6所示。
本发明采用定点饱和突变的方法对SEQ ID NO.6所示的α-淀粉酶BasAmy的第29位、第267位、第270位、第275位和第350位进行分子改造,经过高通量筛选确定了第29位、第267位、第270位、第275位和第350位这5个位点的最优突变氨基酸。其中29位由L突变为A最好,267位则是S突变为Q,270位则是S突变为P,275位则是A突变为Y,350位则是D突变为G。
同时采用易错PCR技术对SEQ ID NO.1所示的α-淀粉酶BasAmy的核苷酸序列进行改造,从而获得一系列的突变位点。经过高通量筛选获得了6个有效突变体分别为A112R,L269F,K274S,Q278S,S279Q和L412C。
在上述有效突变位点的基础上,分别一一进行组合,最终得到了四个提高比活的Bsamy突变体分别命名为BasAmy-1、BasAmy-2、BasAmy-3和BasAmy-4。这四个突变体的相对比活分别是BasAmy的130%,160%,180%和125%。BasAmy-1、BasAmy-2、BasAmy-3和BasAmy-4突变体的核苷酸序列如SEQ ID NO.2到SEQ ID NO.5所示,氨基酸序列如SEQ IDNO.7到SEQ ID NO.10所示。
其中BasAmy-1包含的突变位点为L29A,A112R,S267Q,K274S,Q278S,S279Q,D356G和L412C。
其中BasAmy-2包含的突变位点为L29A,L269F,S270P,A275Y,Q278S,S279Q,D356G和L412C。
其中BasAmy-3包含的突变位点为L29A,A112R,L269F,K274S,A275Y,Q278S,S279Q和L412C。
其中BasAmy-4包含的突变位点为S267Q,L269F,S270P,K274S,A275Y,Q278S,S279Q和L412C。
本发明通过蛋白理性改造和高通量筛选技术对索诺拉沙漠芽胞杆菌的α-淀粉酶BasAmy进行分子改造,得到了四个比活提高的突变体。为索诺拉沙漠芽胞杆菌的α-淀粉酶的工业化应用奠定基础。
附图说明
图1原始α-淀粉酶和突变体BasAmy-1至BasAmy-4的最适反应pH
图2原始α-淀粉酶和突变体BasAmy-1至BasAmy-4的pH稳定性
图3原始α-淀粉酶和突变体BasAmy-1至BasAmy-4的最适反应温度
图4原始α-淀粉酶和突变体BasAmy-1至BasAmy-4的热稳定性
具体实施方式
以下实施例中未作具体说明的分子生物学实验方法,均参照《分子克隆实验指南》(第三版)J.萨姆布鲁克一书中所列的具体方法进行,或者按照试剂盒和产品说明书进行;所述试剂和生物材料,如无特殊说明,均可从商业途径获得。
实验材料和试剂:
1、菌株与载体
索诺拉沙漠芽胞杆菌(Bacillus sonorensis)的α-淀粉酶购自中国工业微生物菌种保藏管理中心,菌种编号为10848、大肠杆菌菌株Topl0、毕赤酵母X33、载体pPICzαA,载体pGAPzαA,Zeocin购自Invitrogen公司。
2、酶与试剂盒
Q5高保真Taq酶MIX购自NEB公司,质粒提取,胶纯化,限制性内切酶、试剂盒购自上海生工公司。
3、培养基
大肠杆菌培养基为LB(1%蛋白胨,0.5%酵母提取物,1%NaCl,pH7.0)。LBZ为LB培养基加25ug/mL Zeocin。
酵母培养基为YPD(1%酵母提取物,2%蛋白胨,2%葡萄糖)。酵母筛选培养基为YPDZ(YPD+100mg/L zeocin)。
酵母诱导培养基BMGY(I%酵母提取物、2%蛋白胨、1.34%YNB、0.00004%Biotin、1%甘油(V/V))和BMMY(除以0.5%甲醇代替甘油,其余成份相与BMGY相同)。
实施例1、索诺拉沙漠芽胞杆菌(Bacillus sonorensis)的α-淀粉酶的克隆
将索诺拉沙漠芽胞杆菌接入LB培养基,培养24小时后,提取其基因组DNA。根据已报道索诺拉沙漠芽胞杆菌α-淀粉酶的序列(Genebank:AOFM01000005.1)设计两条引物(R:5'-CTGAATTCATGGTTTACAAATGCAAACGG-3'和F:5'-CTTCTAGACTATCGTTGGACATAAATCGA-3')用于扩增索诺拉沙漠芽胞杆菌α-淀粉酶基因。将扩增的PCR产物纯化回收,分别连接到表达载体pPICzαA和pPGAPzαA,得到表达载体pPICzαA-Basamy和pGAPzαA-Basamy。
实施例2、理性定点突变
以上述pPICzαA-Basamy为模板,以表中的引物进行PCR扩增,具体地扩增反应体系如下:
Q5高保真Taq酶MIX 23uL
对应突变体引物 1uL
对应突变体引物 1uL
pPICzαA-Basamy(20ng) 2uL
加水至 50uL
反应程序如下:
琼脂糖电泳检测PCR扩增结果,纯化回收PCR产物。用限制性内切酶DpnI将原始质粒分解,将分解完的产物才用热激法转入大肠杆菌Top10,通过菌液PCR验证重组转化子,提取验证正确的转化子的质粒进行测序,从而确定相应的突变体。将测序正确的突变体,用SacI线性化,转入毕赤酵母X33。
实施例3、高通量筛选高比活突变菌株
将实施例2中的酵母重组转化子用牙签逐个挑至24孔板,每个孔中加入1mL含有BMGY培养基,30℃,220rpm培养24h左右,离心去上清。再分别加入1.6mL BMMY培养基进行诱导培养。培养24h后,离心取上清,将上述上清液分别取出200μL至96孔板,进行α-淀粉酶酶活测定。α-淀粉酶酶活检测参照中华人民共和国国家标准《GB/T 24401-2009》进行测定。经过高通量筛选得到5个有效突变位点分别为L29A,S267Q,S270P,A275Y和D350G。这5个突变体的相对比活如表1所示。
表1原始α-淀粉酶和突变体α-淀粉酶相对比活
编号 相对比活(%)
原始α-淀粉酶 100
L29A 115
S267Q 120
S270P 125
A275Y 119
D350G 128
实施例4、易错PCR非理性改造
以上述pGAPzαA-Basamy为模板,进行易错PCR随机突变扩增,具体地扩增方法是:
第一轮扩增:以载体启动子引物AOX5-F和AOX3-R为引物进行PCR扩增,反应体系如下:
反应程序如下:
回收第一轮PCR产物,去1μL稀释50-100倍用作第二轮PCR的模板;第二,第三轮易错PCR以α-淀粉酶特异性引物R及F替代引物AOX5-F和AOX3-R为反应引物,重复PCR反应。取第二、三轮的产物用XbaI和EcoRI进行双酶切,连接至pGAPzαA载体上的EcoRI和XbaI位点之间。连接产物转化X33,在YPDZ平板培养筛选突变菌株。经过高通量筛选获得了6个有效突变体分别为A112R,L269F,K274S,Q278S,S279Q和L412C。这6个突变体的相对比活如表2所示。
表2原始α-淀粉酶和突变体α-淀粉酶相对比活
编号 相对比活(%)
原始α-淀粉酶 100
A112R 121
L269F 130
K274S 126
Q278S 131
S279Q 123
L412C 125
实施例5、组合突变
进行组合突变,通过实验最终得到4个组合突变分别命名为BasAmy-1、BasAmy-2、BasAmy-3、BasAmy-4。
其中BasAmy-1包含的突变位点为L29A,A112R,S267Q,K274S,Q278S,S279Q,D356G和L412C。
其中BasAmy-2包含的突变位点为L29A,L269F,S270P,A275Y,Q278S,S279Q,D356G和L412C。
其中BasAmy-3包含的突变位点为L29A,A112R,L269F,K274S,A275Y,Q278S,S279Q和L412C。
其中BasAmy-4包含的突变位点为S267Q,L269F,S270P,K274S,A275Y,Q278S,S279Q和L412C。
实施例6、原始α-淀粉酶及α-淀粉酶突变体的比活分析
分别将原始α-淀粉酶和突变体α-淀粉酶进行纯化,纯化方法为镍柱纯化。将纯化好的α-淀粉酶和突变体α-淀粉酶分别测定相应的酶活并计算出比活。以突变体比活除以原始α-淀粉酶比活,来计算突变体的相对比活。最终BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的相对比活分别为130%,160%,180%和125%。
实施例7、原始α-淀粉酶及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适反应pH及pH稳定性
参照国标方法测定原始α-淀粉酶BasAmy及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适反应pH。BasAmy及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适反应pH如图1所示。由图1可知,突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适pH值几乎和BaAmy一样,均为6.0。
将BasAmy及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4分别在pH4-8条件下室温处理2小时,然后参照国标的方法测定酶活,结果如图2所示。由图2可知突变体BasAmy-1、BasAmy-2、BasAmy-3和BasAmy-4的pH稳定性与BasAmy一致。
实施例8、原始α-淀粉酶及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适反应温度及热稳定性
参照国标方法测定BasAmy及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适反应温度,结果如图3所示。由图3可知,BasAmy及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的最适反应温度均为60℃。
将BasAmy及突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4分别在50℃-90℃条件下水浴处理30分钟,然后参照国标的方法测定酶活,结果如图4所示。由图4可知,突变体BasAmy-1,BasAmy-2,BasAmy-3和BasAmy-4的热稳定性与BasAmy一致。

Claims (8)

1.提高比活的α-淀粉酶BasAmy突变体,其特征在于,所述突变体为氨基酸序列如SEQID NO.6所示的α-淀粉酶BasAmy的突变体,突变位置为以下位点中的一个或多个,
所述突变位点为:氨基酸序列如SEQ ID NO.6所示的α-淀粉酶BasAmy的29位由L突变为A;267位由S突变为Q;270位由S突变为P;275位由A突变为Y;350位由D突变为G;112位由A突变为R;269位由L突变为F;274位由K突变为S;278位由Q突变为S;279位由S突变为Q;和/或412为由L突变为C。
2.根据权利要求1所述的提高比活的α-淀粉酶BasAmy突变体,其特征在于,所述突变体的突变位点为:
L29A,A112R,S267Q,K274S,Q278S,S279Q,D356G和L412C;
L29A,L269F,S270P,A275Y,Q278S,S279Q,D356G和L412C;
L29A,A112R,L269F,K274S,A275Y,Q278S,S279Q和L412C;或者
S267Q,L269F,S270P,K274S,A275Y,Q278S,S279Q和L412C。
3.编码权利要求1所述提高比活的α-淀粉酶BasAmy突变体的基因。
4.包含权利要求3所述基因的重组载体。
5.包含权利要求3所述基因的宿主细胞。
6.权利要求1所述提高比活的α-淀粉酶BasAmy突变体的应用。
7.提高α-淀粉酶BasAmy比活的方法,其特征在于,将氨基酸序列如SEQ ID NO.6所示的α-淀粉酶BasAmy的29位由L突变为A;267位由S突变为Q;270位由S突变为P;275位由A突变为Y;350位由D突变为G;112位由A突变为R;269位由L突变为F;274位由K突变为S;278位由Q突变为S;279位由S突变为Q;和/或412为由L突变为C。
8.制备提高比活的α-淀粉酶BasAmy突变体的方法,所述方法包括在宿主细胞中表达权利要求3所述基因并纯化突变体的步骤。
CN201710030849.7A 2017-01-16 2017-01-16 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用 Active CN106929495B (zh)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CN201911068115.3A CN110628748B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-2及其编码基因和应用
CN201710030849.7A CN106929495B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用
CN201911068186.3A CN110699337B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-4及其编码基因和应用
CN201911068182.5A CN110713999B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-3及其编码基因和应用
PCT/CN2017/107821 WO2018129985A1 (zh) 2017-01-16 2017-10-26 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710030849.7A CN106929495B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用

Related Child Applications (3)

Application Number Title Priority Date Filing Date
CN201911068182.5A Division CN110713999B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-3及其编码基因和应用
CN201911068186.3A Division CN110699337B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-4及其编码基因和应用
CN201911068115.3A Division CN110628748B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-2及其编码基因和应用

Publications (2)

Publication Number Publication Date
CN106929495A true CN106929495A (zh) 2017-07-07
CN106929495B CN106929495B (zh) 2020-05-22

Family

ID=59444721

Family Applications (4)

Application Number Title Priority Date Filing Date
CN201911068186.3A Active CN110699337B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-4及其编码基因和应用
CN201911068182.5A Active CN110713999B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-3及其编码基因和应用
CN201710030849.7A Active CN106929495B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用
CN201911068115.3A Active CN110628748B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-2及其编码基因和应用

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CN201911068186.3A Active CN110699337B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-4及其编码基因和应用
CN201911068182.5A Active CN110713999B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-3及其编码基因和应用

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201911068115.3A Active CN110628748B (zh) 2017-01-16 2017-01-16 提高比活的α-淀粉酶突变体BasAmy-2及其编码基因和应用

Country Status (2)

Country Link
CN (4) CN110699337B (zh)
WO (1) WO2018129985A1 (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018129985A1 (zh) * 2017-01-16 2018-07-19 广东溢多利生物科技股份有限公司 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1277258A (zh) * 1999-06-10 2000-12-20 花王株式会社 突变α-淀粉酶

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9708887B1 (pt) * 1996-04-30 2014-10-29 Novozymes As "variante de uma alfa-amilase, uso da mesma, construção de dna, vetor de expressão recombinante, célula de bactéria ou fungo, aditivo e composição detergente".
US5763385A (en) * 1996-05-14 1998-06-09 Genencor International, Inc. Modified α-amylases having altered calcium binding properties
JP4417532B2 (ja) * 1999-06-10 2010-02-17 花王株式会社 変異α−アミラーゼ
US20080280328A1 (en) * 2005-11-18 2008-11-13 Novozymes A/S Glucoamylase Variants
EP2300605A2 (en) * 2008-06-06 2011-03-30 Danisco US Inc. Geobacillus stearothermophilus alpha-amylase (amys) variants with improved properties
WO2014164834A1 (en) * 2013-03-11 2014-10-09 Danisco Us Inc. Alpha-amylase combinatorial variants
PL3034588T3 (pl) * 2014-12-17 2019-09-30 The Procter And Gamble Company Kompozycja detergentu
CN105316300B (zh) * 2015-10-20 2017-03-08 江西省科学院微生物研究所 一种高温活性和热稳定性提高的α‑淀粉酶突变体ApkA‑m及其制备方法和应用
CN110699337B (zh) * 2017-01-16 2023-02-17 广东溢多利生物科技股份有限公司 提高比活的α-淀粉酶突变体BasAmy-4及其编码基因和应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1277258A (zh) * 1999-06-10 2000-12-20 花王株式会社 突变α-淀粉酶

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GENBANK登录号:WP_006637292: "alpha-amylase [Bacillus sonorensis]", 《GENBANK DATABASE》 *
WANG,C.H.等: "Improving the thermostability of alpha-amylase by combinatorial coevolving-site saturation mutagenesis", 《BMC BIOINFORMATICS》 *
薛蓓等: "地芽孢杆菌Geobacillus sp. GXS1α-淀粉酶的饱和突变及酶学性质研究", 《生物技术通讯》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018129985A1 (zh) * 2017-01-16 2018-07-19 广东溢多利生物科技股份有限公司 提高比活的α-淀粉酶BasAmy突变体及其编码基因和应用
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Also Published As

Publication number Publication date
CN110713999A (zh) 2020-01-21
CN110699337A (zh) 2020-01-17
CN110628748A (zh) 2019-12-31
CN110699337B (zh) 2023-02-17
WO2018129985A1 (zh) 2018-07-19
CN110713999B (zh) 2023-03-21
CN110628748B (zh) 2023-03-31
CN106929495B (zh) 2020-05-22

Similar Documents

Publication Publication Date Title
Ding et al. Agrobacterium tumefaciens mediated fused egfp-hph gene expression under the control of gpd promoter in Pleurotus ostreatus
CN108251392B (zh) 提高比活和热稳定性的葡萄糖氧化酶突变体及其编码基因和应用
CN108374001A (zh) 提高比活的葡萄糖氧化酶突变体及其编码基因和应用
CN109943546B (zh) 一种谷氨酰胺转氨酶突变体及其制备方法和应用
CN105368866B (zh) 改良ATMT在构建深绿木霉T23△Crel中的应用
CN106754825A (zh) 提高比活的α‑淀粉酶BaAmy突变体及其编码基因和应用
CN108004220B (zh) 提高热稳定性的碱性蛋白酶BmP突变体及其基因和应用
Kim et al. Identification and functional analysis of pheromone and receptor genes in the B3 mating locus of Pleurotus eryngii
CN114395541B (zh) 一种热稳定性和比活提高的葡萄糖氧化酶突变体GOx1-MUT、其编码基因和应用
CN106929495A (zh) 提高比活的α‑淀粉酶BasAmy突变体及其编码基因和应用
Naumova et al. Molecular polymorphism of β-fructosidase SUC genes in the Saccharomyces yeasts
CN106754826A (zh) 活性提高的α‑淀粉酶AmyL突变体及其编码基因和应用
CN107058264A (zh) 比活提高的α‑淀粉酶JcAmy突变体及其编码基因和应用
CN109337845B (zh) 一种不动杆菌y-3l-天冬酰胺酶基因及其表达与应用
CN111944790A (zh) 中性蛋白酶基因、中性蛋白酶及其制备方法和应用
CN108034642B (zh) 葡萄糖氧化酶CnGOD19及其改良酶、基因和应用
Dörnte et al. Selection markers for transformation of the sequenced reference monokaryon Okayama 7/# 130 and homokaryon AmutBmut of Coprinopsis cinerea
Kim et al. Genome-wide identification and characterization of novel laccase genes in the white-rot fungus Flammulina velutipes
CN107488673B (zh) 一种香蕉束顶病毒侵染性克隆及构建方法
CN105296453B (zh) 一株高活性克拉维胺酸氨基乙酰化酶的棒状链霉菌及其应用
CN112553090A (zh) 一株高产sorbicillinoids的里氏木霉工程菌及其构建方法与应用
EP3296401B1 (en) Method for selective carbon source-independent expression of protein-encoding sequences in a filamentous fungus cell
RU2439157C2 (ru) ГЕНЕТИЧЕСКАЯ КОНСТРУКЦИЯ ДЛЯ ПОЛУЧЕНИЯ СТАБИЛЬНЫХ ТРАНСФОРМАНТОВ ГРИБОВ РОДА Rhizopus
Nakahara et al. Cloning and sequencing of endochitinase genes from Gliocladium virens and Trichoderma species
CN115927267A (zh) 一种胆汁酸复合酶制剂及其在制备提高动物蛋白消化率的饲料添加剂中的应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant